Anemia of chronic kidney disease: Treat it, but not too aggressively.
Cleve Clin J Med. 2016 Aug;83(8):613-624
Authors: Nakhoul G, Simon JF
Anemia of renal disease is common and is associated with significant morbidity and death. It is mainly caused by a decrease in erythropoietin production in the kidneys and can be partially corrected with erythropoiesis-stimulating agents (ESAs). However, randomized controlled trials have shown that using ESAs to target normal hemoglobin levels can be harmful, and have called into question any benefits of ESA treatment other than avoidance of transfusions.
PMID: 27505883 [PubMed - as supplied by publisher]